Frog eggs help researchers understand repair of DNA damages

January 20, 2019

The DNA replication process, which takes place every time a cell divides, also triggers repair of DNA damage, researchers from the University of Copenhagen have described in a new study, where they have studied extracts from frog eggs, whose proteins are very similar to those of human cells. The researchers hope the new research results can be used to develop more effective treatments for cancer in the long run.

The body's DNA is subject to constant damages and lesions, which the body must repair. But precisely how the body does this, has not been established in full. Now researchers from the University of Copenhagen have uncovered some of the pathways used by the cells to repair DNA damages. The research results have been published in the scientific journal Molecular Cell.

Harmful DNA lesions may occur in a number of ways and can both be a result of internal and external factors. The type of damage studied by the researchers is called DNA-protein crosslinks. It is a type of damage that is very difficult to study. To do so, the researchers prepared protein extracts from frog eggs, which recapitulates the repair of the lesion in a test tube. These extracts contain the same proteins that are found in human cells, and therefore represent a good model to study these lesions.

'It is vital to understand how these damages are repaired, because if they are not corrected, the body will develop cancer and accelerated aging. But it is also central knowledge with regard to cancer and chemotherapy. Most chemotherapeutic agents deliberately induce these kinds of damages. If we are able to understand how the damages are repaired, we can use that knowledge to develop a form of combination treatment, where we induce damage, on the one hand, and inhibit the cancer cells' repair hereof, on the other. This would give us a more efficient way of killing cancer cells,' says last author of the study, Associate Professor Julien Duxin from the Novo Nordisk Foundation Center for Protein Research.

DNA Replication Triggers Repair

DNA damage inhibits cell division, and that is also how many forms of chemotherapeutic agents kill cancer cells. The researchers have discovered two methods or pathways used to mend DNA-protein crosslinks. At the same time, they have established how DNA replication triggers these repair processes. Associate Professor Julien Duxin compares DNA replication to a motorway and a lesion to a roadblock or a large rock in the middle of the road. For DNA replication to take place and be successful, the roadblock must first be removed.

'Cancer cells divide faster than normal cells and therefore require more DNA replication. They are therefore very sensitive to damages that disturb the replication process. However, DNA replication can also trigger damage repair. For example, you can compare DNA replication to a motorway filled with cars. If you place a rock in the middle of the road, where no one drives, no one will notice the rock. But if you are on a road that is blocked, you will realise that there is a problem that requires solving,' says Associate Professor Julien Duxin.

Cancer cells are clever and often find a way to repair themselves. For example, chemotherapy for one type of cancer cells may work for a period of six months and then stop working because the cancer cells have found a new way of removing and repairing lesions. Therefore, the next step for the researchers is to continue to study these lesions and seek to identify more pathways in which they are repaired. They focus especially on the types of DNA damages that occur during chemotherapy and how they are repaired.
-end-
Associate Professor Julien Duxin
Phone: +45 35320731 / +45 93565571
Email: julien.duxin@cpr.ku.dk

University of Copenhagen The Faculty of Health and Medical Sciences

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.